Scientific Advisor: Kerry Fisher PhD

Kerry Fisher has been working in the field of oncolytic viruses for over 15 years and is a founding scientist of PsiOxus Therapeutics and previously Hybrid Systems.  He was awarded a PhD in therapeutic gene delivery from the University of Birmingham and has specialized in the systemic administration of viruses for the treatment of cancer.   He is particularly interested in how viruses replicate, spread and stimulate immune cells within the tumor microenvironment.   Kerry holds a research lectureship at the University of Oxford and has published over 60 publications in the field of oncolytic viruses and filed over 20 patent applications.

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image